Healthcare provider profile · identity verified

Jacinto Parcon Casio, MD

Internal Medicine · NASHUA, NH · NPI 1689691412

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	598	180
Amlodipine Besylate	Amlodipine Besylate	327	108
Lisinopril	Lisinopril	288	87
Omeprazole	Omeprazole	282	78
Levothyroxine Sodium	Levothyroxine Sodium	266	80
Losartan Potassium	Losartan Potassium	259	79
Albuterol Sulfate Hfa	Albuterol Sulfate	207	68
Metformin Hcl Er	Metformin Hcl	196	53
Gabapentin	Gabapentin	179	49
Pantoprazole Sodium	Pantoprazole Sodium	163	48
Simvastatin	Simvastatin	152	47
Rosuvastatin Calcium	Rosuvastatin Calcium	144	46
Alprazolam	Alprazolam	143	31
Tamsulosin Hcl	Tamsulosin Hcl	135	37
Sertraline Hcl	Sertraline Hcl	133	40
Metoprolol Succinate	Metoprolol Succinate	125	37
Clonazepam	Clonazepam	122	25
Bupropion Xl	Bupropion Hcl	121	28
Diclofenac Sodium	Diclofenac Sodium	111	35
Metformin Hcl	Metformin Hcl	109	35
Trazodone Hcl	Trazodone Hcl	99	34
Fluoxetine Hcl	Fluoxetine Hcl	95	20
Hydrochlorothiazide	Hydrochlorothiazide	92	34
Eliquis	Apixaban	85	22
Jardiance	Empagliflozin	84	16
Famotidine	Famotidine	83	22
Zolpidem Tartrate	Zolpidem Tartrate	82	28
Furosemide	Furosemide	77	23
Atenolol	Atenolol	75	22
Duloxetine Hcl	Duloxetine Hcl	75	16
Metoprolol Tartrate	Metoprolol Tartrate	71	20
Alendronate Sodium	Alendronate Sodium	69	14
Synthroid	Levothyroxine Sodium	62	12
Potassium Chloride	Potassium Chloride	61	13
Pravastatin Sodium	Pravastatin Sodium	61	13
Baclofen	Baclofen	56	19
Lorazepam	Lorazepam	54	18
Paroxetine Hcl	Paroxetine Hcl	53	12
Ibuprofen	Ibuprofen	51	18
Allopurinol	Allopurinol	49	15
Mirtazapine	Mirtazapine	49	15
Oxycodone Hcl	Oxycodone Hcl	48	12
Escitalopram Oxalate	Escitalopram Oxalate	47	13
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Glipizide	Glipizide	44	12
Chlorthalidone	Chlorthalidone	41	13
Glimepiride	Glimepiride	40	13
Buspirone Hcl	Buspirone Hcl	39	12
Hydroxyzine Hcl	Hydroxyzine Hcl	37	11
Pregabalin	Pregabalin	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Promethazine Hcl	Promethazine Hcl	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	14
Ozempic	Semaglutide	32	11
Valacyclovir	Valacyclovir Hcl	32	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	27
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	19
Creon	Lipase/Protease/Amylase	28	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	15
Meclizine Hcl	Meclizine Hcl	25	suppressed
Valsartan	Valsartan	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Temazepam	Temazepam	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Bydureon Bcise	Exenatide Microspheres	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Carvedilol	Carvedilol	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Finasteride	Finasteride	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	15
Propranolol Hcl	Propranolol Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Irbesartan	Irbesartan	16	suppressed
Methylphenidate Er	Methylphenidate Hcl	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Clonidine Hcl	Clonidine Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Azithromycin	Azithromycin	12	12
Dutasteride	Dutasteride	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Torsemide	Torsemide	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Fenofibrate	Fenofibrate	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Nystatin	Nystatin	11	suppressed
Topiramate	Topiramate	11	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error